539997 KWALITY

Kwality Pharmaceuticals Share Price

 

 

Start SIP in KWALITY

Start SIP

Performance

  • Low
  • ₹1,051
  • High
  • ₹1,073
  • 52 Week Low
  • ₹596
  • 52 Week High
  • ₹1,235
  • Open Price₹1,073
  • Previous Close₹1,073
  • Volume4,950
  • 50 DMA₹1,026.02
  • 100 DMA₹993.85
  • 200 DMA₹950.84

Investment Returns

  • Over 1 Month + 4.05%
  • Over 3 Month + 21.31%
  • Over 6 Month -8.28%
  • Over 1 Year + 24.5%

Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!

Invest Now

Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 22.6
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 1,108
  • P/B Ratio
  • 3.8
  • Average True Range
  • 62.59
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 35.28
  • RSI
  • 51.42
  • MFI
  • 59.87

Kwality Pharmaceuticals Financials

Kwality Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,068.00
-5.45 (-0.51%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹1,077.13
  • 50 Day
  • ₹1,026.02
  • 100 Day
  • ₹993.85
  • 200 Day
  • ₹950.84

Resistance and Support

1067.85 Pivot Speed
  • R3 1,145.50
  • R2 1,117.75
  • R1 1,095.60
  • S1 1,045.70
  • S2 1,017.95
  • S3 995.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kwality Pharmaceuticals has an operating revenue of Rs. 422.61 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 15% is great, ROE of 15% is good. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 10% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-19 Audited Results
2025-01-31 Quarterly Results
2024-10-30 Quarterly Results

Kwality Pharmaceuticals F&O

Kwality Pharmaceuticals Shareholding Pattern

54.83%
0%
33.67%
11.5%

About Kwality Pharmaceuticals

  • NSE Symbol
  • KWALITY
  • BSE Symbol
  • 539997
  • Managing Director
  • Mr. Ramesh Arora
  • ISIN
  • INE552U01010

Similar Stocks to Kwality Pharmaceuticals

Kwality Pharmaceuticals FAQs

Kwality Pharmaceuticals share price is ₹1,068 As on 21 January, 2026 | 10:46

The Market Cap of Kwality Pharmaceuticals is ₹1108.2 Cr As on 21 January, 2026 | 10:46

The P/E ratio of Kwality Pharmaceuticals is 22.6 As on 21 January, 2026 | 10:46

The PB ratio of Kwality Pharmaceuticals is 3.8 As on 21 January, 2026 | 10:46

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23